Ionization failure not due to resistance.

1. González C, Rubio M, Romero Vivas J, González M, Picazo JJ. Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-sensitive organisms. Clin Infect Dis 1999;29:1171–7. 2. Georges H, Leroy O, Alfandari S, et al. Pulmonary disposition of vancomycin in critically ill patients. Eur J Clin Microbiol Infect Dis 1997;16:385–8. 3. Romero-Vivas J, Rubio M, Fernández C, Picazo JJ. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1995;21:1417–23. 4. Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 1991;115:674–80. 5. Small PM, Chambers HF. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug abusers. Antimicrob Agents Chemother 1990;34: 1227–31. 6. Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997;350:1644–5. 7. Marchese A, Balistreri G, Tonoli E, et al. Heterogeneos vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital. J Clin Microbiol 2000;38:866–9. 8. Howe RA, Wootton M, Walsh TR, et al. Expression and detection of heterovancomycin resistance in Staphylococcus aureus. J Antimicrob Chemother 1999;44:675–8. 9. Hubert SK, Mohammed IM, Fridkin SK, Gaynes RP, McGowan JE, Tenover FC. Glycopeptide-intermediate Staphylococcus aureus: evaluation of a novel screening method and results of a survey of selected US hospitals. J Clin Microbiol 1999;37:3590–3.